ctrl K

Watchlist Price Alert

Eiger BioPharmaceuticals ... (EIGR)

NASDAQ: EIGR · Real-Time Price · USD

1.73

0.00 (0.29%)

At close: Apr 03, 2024, 3:59 PM

1.73

0.00%

After-hours: Jun 16, 2025, 04:00 PM EDT

Eiger BioPharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	15.77M	13.48M	12.14M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	24K	1.84M	745K	645K	486K	54K	41K	23K
Gross Profit	15.75M	11.65M	11.4M	-645K	-486K	-54K	-41K	-23K
Operating Income	-71.79M	-92.74M	-76.94M	-62.15M	-68.9M	-51.05M	-41.52M	-46.12M
Interest Income	2.21M	1.08M	158K	704K	2.07M	997K	410K	n/a
Pretax Income	-74.96M	-96.75M	-33.85M	-65.05M	-70.25M	-52.39M	-42.45M	-47.09M
Net Income	-74.96M	-96.78M	-33.92M	-68.63M	-73.64M	-52.39M	-42.45M	-47.09M
Selling & General & Admin	25.2M	29.11M	23.9M	20.56M	17.11M	13.96M	12M	13.11M
Research & Development	62.33M	75.28M	64.44M	41.59M	51.79M	37.09M	29.52M	33.01M
Other Expenses	n/a	-963K	46.49M	-12K	-15K	-12K	186K	-277K
Operating Expenses	87.53M	104.39M	88.34M	62.15M	68.9M	51.05M	41.52M	46.12M
Interest Expense	5.47M	4.13M	3.56M	3.59M	3.41M	2.33M	1.52M	690K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	87.56M	106.22M	89.08M	62.15M	68.9M	51.05M	41.52M	46.12M
Income Tax Expense	6K	23K	64K	3.58M	3.39M	985K	1.67M	390K
Shares Outstanding (Basic)	1.48M	1.39M	34.63M	29.88M	24.43M	13.63M	8.73M	8.36M
Shares Outstanding (Diluted)	1.48M	1.39M	34.63M	29.88M	24.5M	13.63M	8.73M	8.36M
EPS (Basic)	-50.78	-69.74	-0.98	-2.3	-3.01	-3.84	-4.86	-5.63
EPS (Diluted)	-50.78	-69.74	-0.98	-2.3	-3.01	-3.84	-4.86	-5.63
EBITDA	-68.74M	-92.62M	-76.94M	-60.81M	-66.36M	-50.06M	-40.92M	-46.4M
EBIT	-69.49M	-92.62M	-30.29M	-61.46M	-66.85M	-50.06M	-40.92M	-46.4M
Depreciation & Amortization	750K	119K	46.65M	1.34M	2.54M	54K	41K	23K